NCT01221636View on ClinicalTrials.gov

Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept

Solution for injection, Intravenous, 750 mg, 1 day

Trial Locations (1)

78744

Local Institution, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY